Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 16.329\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] CCc1ccc(NC(=O)CC2C(=O)NCCN2C(=S)Nc2ccccc2)cc1
[b] CCCCN1CN(Cc2ccccc2)CNC1=S
[c] Cc1ccc(S(=O)(=O)NCC(C)NC(=O)CN2CCOCC2)cc1
[d] O=C1CCCN1CCCNc1ccc2nnc(CCC(=O)N3CCN(c4ccccc4F)CC3)n2n1
Answer: c. Cc1ccc(S(=O)(=O)NCC(C)NC(=O)CN2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)NCC(C)NC(=O)CN2CCOCC2)cc1
Cc1ccc(S(=O)(=O)NCC(C)NC(=O)CN2CCOCC2)cc1
N-[1-[(4-methylphenyl)sulfonylamino]propan-2-yl]-2-morpholin-4-ylacetamide